MEDIA RELEASE PR41475
NoblePeak Vision Corp. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
WELLESLEY HILLS, Mass. Sept. 28 /PRNewswire-AsiaNet/ --
Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that assets of NoblePeak Vision Corp. of Wakefield,
Massachusetts have been assigned to him for the benefit of NoblePeak's creditors.
NoblePeak holds numerous patents in germanium (Ge) on silicon processing.
Its TriWave technology is the world's first Germanium-enhanced, CMOS image
sensor technology, which delivers sensitivity and resolution across the
visible, near infrared (NIR) and short wave infrared (SWIR) spectrum.
The intellectual property, fixed assets and inventory will be sold by a
sealed bid sale at 12:00 noon on November 5, 2010.
Persons interested in bidding must sign a Confidentiality Disclosure
Agreement ("CDA") obtained from Finn's Office - jffinnjr@finnwarnkegayton.com
or 781-237-8840. They will then receive a bid package.
About Joseph F. Finn, Jr., C.P.A.
Joseph F. Finn, Jr., C.P.A. is the owner of the firm Finn, Warnke &
Gayton, Certified Public Accountants of Wellesley Hills, Massachusetts. He
works primarily in the area of management consulting for distressed
enterprises, bankruptcy accounting and related matters, such as assignee for
the benefit of creditors and liquidating agent for a corporation. He has been
involved in a number of loan workouts and bankruptcy cases for thirty-five
(35) years. His most recent Assignments for the Benefit of Creditors in the
biotech field include Spherics, Inc., ActivBiotics, Inc., Prospect
Therapeutics, Inc. and Epix Pharmaceuticals, Inc.
For further information, please contact Joseph F. Finn, Jr., C.P.A. at
781-237-8840 or jffinnjr@finnwarnkegayton.com
SOURCE Joseph F. Finn, Jr., C.P.A.
CONTACT: Joseph F. Finn, Jr., C.P.A., +1-781-237-8840,
jffinnjr@finnwarnkegayton.com
NEWS 
